Information for "Template:Cardiac stimulants excluding cardiac glycosides"

Basic information

Display title	Template:Cardiac stimulants excluding cardiac glycosides
Default sort key	Cardiac stimulants excluding cardiac glycosides
Page length (in bytes)	1,168
Namespace ID	10
Namespace	Template
Page ID	100543
Page content language	en - English
Page content model	wikitext
Indexing by robots	Allowed
Number of redirects to this page	1

Edit	Allow all users (infinite)
Move	Allow all users (infinite)

Total number of edits	0
Recent number of edits (within past 30 days)	0
Recent number of distinct authors	0

Transcluded templates (6)	Templates used on this page: Template:Navbox (view source) Module:Arguments (view source) Module:Color contrast (view source) Module:Color contrast/colors (view source) Module:Navbar (view source) Module:Navbox (view source)
Pages transcluded on (23)	Templates used on this page: Amezinium metilsulfate (view source) (protected) Angiotensinamide (view source) (protected) Arbutamine (view source) (protected) Bucladesine (view source) (protected) Cafedrine (view source) (protected) Dimetofrine (view source) (protected) Dopamine (view source) Dopexamine (view source) (protected) Enoximone (view source) (protected) Etilefrine (view source) (protected) Ibopamine (view source) (protected) Isuprel (view source) (protected) Levosimendan (view source) (protected) Mephentermine (view source) (protected) Methoxamine (view source) (protected) Norfenefrine (view source) (protected) PDE3 inhibitor (view source) (protected) Phosphodiesterase inhibitors (view source) (protected) Prenalterol (view source) (protected) Synephrine (view source) (protected) The Living Textbook of Cardiovascular Pharmacology (view source) Theodrenaline (view source) (protected) Xamoterol (view source) (protected)